LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts-Reference-Cited by-同舟云学术

LV systolic impairment in patients with asymptomatic coronary heart disease and type 1 diabetes is related to coronary atherosclerosis, glycaemic control and advanced glycation endproducts

Published:2007-10 Issue:10 Volume:9 Page:1044-1050
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Steine Kjetil¹,Larsen Jakob R.²,Stugaard Marie¹,Berg Tore Julsrud¹,Brekke Magne²,Dahl-Jørgensen Knut²

Affiliation:

1. Aker University Hospital; N-0514 Oslo Norway

2. Ullevål University Hospital; Oslo Norway

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.ejheart.2007.07.013/fullpdf

Reference35 articles.

1. Influence of diabetes mellitus on heart failure risk and outcome;Bauters;Cardiovasc Diabetol,2003

2. Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease;Zieman;Drugs,2004

3. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats;Norton;Circulation,1996

4. Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease;Shishehbor;Am J Cardiol,2003

5. Comparison of echocardiographic variables between type I diabetics and normal controls;Fraser;Am J Cardiol,1995

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced glycation end product signaling and metabolic complications: Dietary approach;World Journal of Diabetes;2023-07-15

2. Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure;Biomedicines;2023-03-15

3. The role of serum and dietary advanced glycation endproducts in relation to cardiac function and structure: The Hoorn Study;Nutrition, Metabolism and Cardiovascular Diseases;2021-10

4. Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes;Oxidative Medicine and Cellular Longevity;2019-12-06

5. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review;Molecular Medicine;2018-11-23